Vanda Pharmaceuticals (VNDA) Share-based Compensation Growth (5y) (2015 - 2025)
Vanda Pharmaceuticals (VNDA) Share-based Compensation Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -25.34% |
| Sep 30, 2024 | -31.47% |
| Jun 30, 2024 | -0.75% |
| Mar 31, 2024 | 1.78% |
| Dec 31, 2023 | -41.56% |
| Sep 30, 2023 | 1.97% |
| Jun 30, 2023 | 3.61% |
| Mar 31, 2023 | 6.67% |
| Dec 31, 2022 | 6.34% |
| Sep 30, 2022 | -14.68% |
| Jun 30, 2022 | 7.60% |
| Mar 31, 2022 | 16.19% |
| Dec 31, 2021 | 12.41% |
| Sep 30, 2021 | 13.47% |
| Jun 30, 2021 | 12.52% |
| Mar 31, 2021 | 11.52% |
| Dec 31, 2020 | 11.22% |
| Sep 30, 2020 | 8.75% |
| Jun 30, 2020 | 8.22% |
| Mar 31, 2020 | 15.19% |